
What do we learn from the 2016 American College of Cardiology expert consensus decision pathway on nonstatin therapies for low-density lipoprotein-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk?
Author(s) -
Yutao Guo
Publication year - 2016
Publication title -
cardiology plus
Language(s) - English
Resource type - Journals
eISSN - 2470-752X
pISSN - 2470-7511
DOI - 10.4103/2470-7511.248359
Subject(s) - disease , medicine , atherosclerotic cardiovascular disease , cardiology , cholesterol , intensive care medicine , bioinformatics , biology